Wells Fargo & Company Pro Phase Labs, Inc. Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Pro Phase Labs, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 1,530 shares of PRPH stock, worth $3,350. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,530

Previous 1,637 6.54%

Holding current value

$3,350

Previous $10,000 40.0%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$4.18 - $7.35 $447 - $786	-107 Reduced 6.54%	1,530 $6,000
Q1 2024 May 10, 2024	BUY	$4.47 - $6.47 $4 - $6	1 Added 0.06%	1,637 $10,000
Q4 2023 Feb 09, 2024	BUY	$4.35 - $5.1 $56 - $66	13 Added 0.8%	1,636 $7,000
Q3 2023 Nov 13, 2023	SELL	$4.23 - $7.53 $29 - $52	-7 Reduced 0.43%	1,623 $7,000
Q2 2023 Aug 15, 2023	BUY	$7.15 - $9.78 $64 - $88	9 Added 0.56%	1,630 $11,000
Q1 2023 May 12, 2023	BUY	$6.62 - $9.57 $6 - $9	1 Added 0.06%	1,621 $12,000
Q4 2022 Feb 13, 2023	BUY	$8.78 - $12.47 $35 - $49	4 Added 0.25%	1,620 $15,000
Q3 2022 Nov 14, 2022	BUY	$8.96 - $14.7 $8 - $14	1 Added 0.06%	1,616 $18,000
Q2 2022 Aug 12, 2022	BUY	$6.52 - $13.24 $45 - $92	7 Added 0.44%	1,615 $20,000
Q4 2021 Feb 14, 2022	BUY	$5.13 - $7.89 $10 - $15	2 Added 0.12%	1,608 $12,000
Q3 2021 Nov 15, 2021	SELL	$4.89 - $7.82 $19 - $31	-4 Reduced 0.25%	1,606 $8,000
Q2 2021 Aug 16, 2021	SELL	$4.61 - $6.83 $4 - $6	-1 Reduced 0.06%	1,610 $9,000
Q1 2021 May 13, 2021	BUY	$6.19 - $16.0 $9,637 - $24,912	1,557 Added 2883.33%	1,611 $12,000
Q3 2020 Nov 05, 2020	SELL	$1.4 - $3.87 $4 - $11	-3 Reduced 5.26%	54 $0
Q2 2020 Aug 13, 2020	BUY	$1.2 - $1.99 $1 - $1	1 Added 1.79%	57 $0
Q1 2020 May 14, 2020	BUY	$1.74 - $2.1 $97 - $117	56 New	56 $0

Others Institutions Holding PRPH

# of Institutions

Shares Held

1.67M

Call Options Held

500

Put Options Held

View Full List

About ProPhase Labs, Inc.

Ticker PRPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 16,024,400
Market Cap $35.1M
Description
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...

More about PRPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Pro Phase Labs, Inc. Transaction History